Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pandion Therapeutics, Inc. (PAND)

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-20Dec-31-19
   10-K10-K
Assets    
Current assets    
Cash and cash equivalents  219.916.0
Accounts receivable  1.01.0
Prepaid expenses and other current assets  3.13.0
    Total current assets  223.920.0
Property and equipment, net  3.41.1
Restricted cash  0.5 
    Total assets  227.921.0
   
Liabilities and stockholders’/members’ equity (deficit)    
Current liabilities:    
    Accounts payable  1.81.2
    Accrued expenses and other current liabilities  3.31.5
    Current portion of deferred revenue  3.84.4
        Total current liabilities  8.97.0
Deferred revenue, net of current portion  3.86.1
Long-term debt, net of issuance costs   3.7
Other long-term liabilities  0.50.1
    Total liabilities  13.116.8
   
Commitments and contingencies (Note 8)    
Redeemable convertible preferred shares, no par value; no shares authorized, issued or outstanding at December 31, 2020; 51,217,321 shares authorized and 35,524,212 shares issued and outstanding at December 31, 2019   47.0
   
Stockholders’/Members’ equity (deficit)    
Preferred stock, par value $.001 per share: authorized, 5,000,000 shares; none issued    
Common stock value    
Incentive shares, no par value; no shares authorized, issued or outstanding at December 31, 2020; 7,717,678 shares authorized and 946,751 shares issued and outstanding at December 31, 2019   0.2
Additional paid-in capital  300.7 
Accumulated deficit  -86.0-43.0
    Total stockholders’/members’ equity (deficit)  214.7-42.8
    Total liabilities, redeemable convertible preferred stock/shares and stockholders’/members’ equity  227.921.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy